Cargando…

Tumor-suppressor role of miR-139-5p in endometrial cancer

BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy of the female genital tract worldwide. MicroRNAs are important gene regulators with critical roles in diverse biological processes, including tumorigenesis. Several study’s show that miR-139-5p is involved in the tumorigenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, JinHui, Li, ChunYu, Jiang, Yi, Wan, YiCong, Zhou, ShuLin, Cheng, WenJun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879796/
https://www.ncbi.nlm.nih.gov/pubmed/29618950
http://dx.doi.org/10.1186/s12935-018-0545-8
_version_ 1783311051865980928
author Liu, JinHui
Li, ChunYu
Jiang, Yi
Wan, YiCong
Zhou, ShuLin
Cheng, WenJun
author_facet Liu, JinHui
Li, ChunYu
Jiang, Yi
Wan, YiCong
Zhou, ShuLin
Cheng, WenJun
author_sort Liu, JinHui
collection PubMed
description BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy of the female genital tract worldwide. MicroRNAs are important gene regulators with critical roles in diverse biological processes, including tumorigenesis. Several study’s show that miR-139-5p is involved in the tumorigenesis and metastasis of various cancers. However, its expression and potential biologic role in endometrial cancer remain to be determined. This study aimed to investigate the miR-139-5p expression and to analyze its function and underlying molecular mechanism in endometrial cancer. METHODS: Expression of miR-139-5p was measured using qRT-PCR. The expression of HOXA10 was detected by Immunofluorescence staining in endometrial cancer tissues and adjacent normal tissues. CCK-8 and colony formation assays were used to assess the effect of miR-139-5p on ECC1 and Ishikawa cell line proliferation. Transwell migration assay was used to study the effect of miR-139-5p on EC cell migration. Luciferase reporter assay and western blot were used to confirm targeting of HOXA10 by miR-139-5p. RESULT: We demonstrated that miR-139-5p was down-regulated in human endometrial cancer compared to their matched adjacent non-tumor tissues. Overexpressed miR-139-5p significantly inhibited endometrial cancer cell viability and migration. Computational algorithm in combination with dual luciferase reporter assays identified HOXA10 as the target of miR-139-5p. HOXA10 expression was downregulated in endometrial cancer cells after miR-139-5p overexpression. The expression level of HOXA10 was significantly increased in endometrial cancer tissues, which was inversely correlated with miR-139-5p expression in clinical endometrial cancer tissues. CONCLUSION: These findings indicate that miR-139-5p targets the HOXA10 transcript and suppresses endometrial cancer cell growth and migration, suggesting that miR-139-5p acts as a tumor suppressive role in human endometrial cancer pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12935-018-0545-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5879796
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58797962018-04-04 Tumor-suppressor role of miR-139-5p in endometrial cancer Liu, JinHui Li, ChunYu Jiang, Yi Wan, YiCong Zhou, ShuLin Cheng, WenJun Cancer Cell Int Primary Research BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy of the female genital tract worldwide. MicroRNAs are important gene regulators with critical roles in diverse biological processes, including tumorigenesis. Several study’s show that miR-139-5p is involved in the tumorigenesis and metastasis of various cancers. However, its expression and potential biologic role in endometrial cancer remain to be determined. This study aimed to investigate the miR-139-5p expression and to analyze its function and underlying molecular mechanism in endometrial cancer. METHODS: Expression of miR-139-5p was measured using qRT-PCR. The expression of HOXA10 was detected by Immunofluorescence staining in endometrial cancer tissues and adjacent normal tissues. CCK-8 and colony formation assays were used to assess the effect of miR-139-5p on ECC1 and Ishikawa cell line proliferation. Transwell migration assay was used to study the effect of miR-139-5p on EC cell migration. Luciferase reporter assay and western blot were used to confirm targeting of HOXA10 by miR-139-5p. RESULT: We demonstrated that miR-139-5p was down-regulated in human endometrial cancer compared to their matched adjacent non-tumor tissues. Overexpressed miR-139-5p significantly inhibited endometrial cancer cell viability and migration. Computational algorithm in combination with dual luciferase reporter assays identified HOXA10 as the target of miR-139-5p. HOXA10 expression was downregulated in endometrial cancer cells after miR-139-5p overexpression. The expression level of HOXA10 was significantly increased in endometrial cancer tissues, which was inversely correlated with miR-139-5p expression in clinical endometrial cancer tissues. CONCLUSION: These findings indicate that miR-139-5p targets the HOXA10 transcript and suppresses endometrial cancer cell growth and migration, suggesting that miR-139-5p acts as a tumor suppressive role in human endometrial cancer pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12935-018-0545-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-02 /pmc/articles/PMC5879796/ /pubmed/29618950 http://dx.doi.org/10.1186/s12935-018-0545-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Liu, JinHui
Li, ChunYu
Jiang, Yi
Wan, YiCong
Zhou, ShuLin
Cheng, WenJun
Tumor-suppressor role of miR-139-5p in endometrial cancer
title Tumor-suppressor role of miR-139-5p in endometrial cancer
title_full Tumor-suppressor role of miR-139-5p in endometrial cancer
title_fullStr Tumor-suppressor role of miR-139-5p in endometrial cancer
title_full_unstemmed Tumor-suppressor role of miR-139-5p in endometrial cancer
title_short Tumor-suppressor role of miR-139-5p in endometrial cancer
title_sort tumor-suppressor role of mir-139-5p in endometrial cancer
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879796/
https://www.ncbi.nlm.nih.gov/pubmed/29618950
http://dx.doi.org/10.1186/s12935-018-0545-8
work_keys_str_mv AT liujinhui tumorsuppressorroleofmir1395pinendometrialcancer
AT lichunyu tumorsuppressorroleofmir1395pinendometrialcancer
AT jiangyi tumorsuppressorroleofmir1395pinendometrialcancer
AT wanyicong tumorsuppressorroleofmir1395pinendometrialcancer
AT zhoushulin tumorsuppressorroleofmir1395pinendometrialcancer
AT chengwenjun tumorsuppressorroleofmir1395pinendometrialcancer